ABOUT THIS EPISODE
https://www.youtube.com/watch?v=QUpHAdaPkMY&list=PLKpkKZ4OxkU7kgB8MVqDoo-t_K17673tF&index=1&t=9s
This episode of Vital Viewpoints on Healthcare unpacks the rapidly evolving regulatory landscape for pharmaceuticals. The discussion covers the challenges to innovation, such as the growing unpredictability in FDA policy, the challenges with reimbursement, and the increasing role of real-world evidence in bringing therapies to market. Julie Tierney, principal at Leavitt Partners (an HMA Company) shares her expert perspectives on rare disease innovation and upcoming user fee negotiations; while Ben Shand, vice president at Health Management Associates, talks about why organizations must actively engage to navigate risk, identify opportunity, and ultimately improve patient access to care.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of HMA Vital Viewpoints on Healthcare.
OTHER EPISODES IN THIS PODCAST
In this episode of Vital Viewpoints on Healthcare, Robert Ross and Warren Brodine from HMA’s Delivery Systems practice explore how hospitals and community health centers can work together to strengthen access, improve health outcomes, and improve financial sustainability across the healthcare syste…
Rebecca Nielsen and Alex Rich, co-leaders of HMA’s Strategy and Transformation practice, have been supporting healthcare strategies in an ever-changing environment defined by constant healthcare disruption from AI, shifting regulatory policies, and financial strain. With so much change in the air n…
As Medicaid faces another set of policy shifts, this episode provides a look-back on the many twists and turns Medicaid has faced throughout the years. Jay Rosen, president and chairman of HMA, reflects on his work with states and health plans over the past four decades in their efforts to deliver …
Michelle Anderson, director and senior consulting actuary at Wakely, an HMA Company, joins Vital Viewpoints on Healthcare to unpack the state of the Affordable Care Act (ACA) marketplace. From the market’s volatile beginnings to today’s uncertainty around subsidies, Michelle shares how insurers, st…
Quality is a word we all use in healthcare, but what does it truly mean for patients, clinicians, and systems striving to improve care? In this episode of Vital Viewpoints on Healthcare, Sarah Hudson Scholle, Principal at Leavitt Partners, an HMA company, and a nationally recognized expert in healt…
Disclaimer: The podcast and artwork embedded on this page are from HMA Vital Viewpoints on Healthcare, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
